title: ST-Elevation Myocardial Infarction After Sumitriptan Ingestion in Patient with Normal Coronary Arteries.
abstract: Sumitriptan has been used by millions as a migraine abortant; however, there have been studies showing angina pectoris, coronary vasospasm, and even myocardial infarction in patients with predisposing cardiac risk factors. The majority are patients using the injectable form subcutaneously. We present the case of a patient who presents with ST-elevation myocardial infarction, with no cardiovascular risk factors, after ingesting oral sumitriptan for her typical migraine.
authors.affiliation: Carl R. Darnall Army Medical Center, Department of Emergency Medicine, Fort Hood, Texas.
authors.forename: Christian
authors.initials: C
authors.lastname: Jensen
authors.affiliation: Carl R. Darnall Army Medical Center, Department of Emergency Medicine, Fort Hood, Texas.
authors.forename: Mark
authors.initials: M
authors.lastname: Riddle
mesh_terms: D004562:Electrocardiography / Q000187:drug effects; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000188:drug therapy; D005996:Nitroglycerin / Q000627:therapeutic use; D018170:Sumatriptan / Q000009:adverse effects* / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D018170:Sumatriptan; D005996:Nitroglycerin